Nobel Committe Under Drug Influence?

  • Thread starter Thread starter George Jones
  • Start date Start date
AI Thread Summary
AstraZeneca is under criminal investigation for potential influence in the awarding of the recent Nobel Prize in medicine. The discussion highlights concerns about the implications of perceived impropriety, emphasizing that the appearance of corruption can be as damaging as actual misconduct. The complexities of funding in academia, including the motivations behind grants and speaking engagements, complicate the situation. There are calls for clear rules regarding industry-sponsored events to prevent conflicts of interest. The investigation's outcome is awaited, with skepticism about whether such accolades significantly impact consumer choices or regulatory approvals in the pharmaceutical industry.
George Jones
Staff Emeritus
Science Advisor
Gold Member
Messages
7,643
Reaction score
1,601
Pharmaceutical giant AstraZeneca currently is the subject of a criminal investigation for possible influence in the awarding of the most recentl Nobel Prize in medicine.

http://www.thestar.com/news/world/article/555701
 
Physics news on Phys.org
George Jones said:
Pharmaceutical giant AstraZeneca currently is the subject of a criminal investigation for possible influence in the awarding of the most recentl Nobel Prize in medicine.

http://www.thestar.com/news/world/article/555701

I don't know but that it looks a little slim. For something like the Nobel the appearance of impropriety is every bit as damaging as actual corruption. Recognizing that it is a complex world though, and there are lots of grant monies funding any number of academic efforts for all sorts of reasons from philanthropy to self interest, it's seemingly a daunting task to be sure that in such an interconnected world that all recusable associations are ferreted out before any damage is done.

Now taking junkets - if that's what it was - that could be another issue that I'd think they would already have rules about. And if they didn't they should. On the other hand an invitation to speak at a conference with an honorarium that covered expenses could as easily be seen as a junket. So I guess that we will have to see what investigation turns up, and hope that good sense would have prevailed. It would surely be disappointing to me if it turns out otherwise.
 
Would it be worth the effort?
The customer isn't going to buy your aspirin/cold medicene over the other because you have a Nobel winner, the FDA aren't going to be persuaded to license the drug any easier. And if you just wanted bragging rights that MegaPharmaCorp had more Nobel winners than GigaDrugsLLC you just poach a few near-retirees from universites.
 

Similar threads

Replies
1
Views
3K
Replies
13
Views
3K
Replies
19
Views
3K
Replies
2
Views
5K
Replies
1
Views
1K
Replies
7
Views
4K
Replies
14
Views
10K
Back
Top